Back to top
more

Labcorp (LH)

(Real Time Quote from BATS)

$235.62 USD

235.62
51,710

+1.24 (0.53%)

Updated Nov 7, 2024 11:08 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Allscripts' (MDRX) Veradigm Partners with PAN Foundation

by Zacks Equity Research

This partnership between Allscripts (MDRX) and PAN Foundation is expected to boost patient outcomes.

Debanjana Dey headshot

Coronavirus Diagnostic Tests in High Demand: 4 Stocks in Focus

by Debanjana Dey

Amid the pandemic, these four companies with strong diagnostics testing developments might show better resilience.

Masimo Launches Masimo SafetyNet-Open to Fight Coronavirus

by Zacks Equity Research

Masimo's (MASI) newly-launched SafetyNet-Open has been developed to ensure health and safety during the coronavirus outbreak.

Trina Mukherjee headshot

Near-Term Outlook Bleak for Medical Dental Supplies Industry

by Trina Mukherjee

Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.

PerkinElmer's Tie-Up to Boost Health Outcomes in Africa

by Zacks Equity Research

PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.

LH vs. ALGN: Which Stock Is the Better Value Option?

by Zacks Equity Research

LH vs. ALGN: Which Stock Is the Better Value Option?

Accuray's New CyberKnife S7 System to Boost Patient Care

by Zacks Equity Research

Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.

Here's Why You Should Retain Glaukos in Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on Glaukos (GKOS) stock, thanks to solid prospects.

ABIOMED Unveils Digital Platform CAMP PCI for CAD Treatment

by Zacks Equity Research

ABIOMED's (ABMD) new digital platform helps to deliver better patient outcomes for those suffering from CAD.

Here's Why You Should Hold on to Intuitive Surgical Stock Now

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.

AMN Healthcare (AMN) Introduces New Customizable Offering

by Zacks Equity Research

AMN Healthcare (AMN) offers a customizable return-to-work solutions as businesses resume operations amid the ongoing pandemic.

Here's Why You Should Add AngioDynamics to Your Portfolio

by Zacks Equity Research

AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.

HMS Holdings' Solution to Help Consumers Amid Coronavirus

by Zacks Equity Research

HMS Holdings (HMSY) offers a unique COVID-19 health management and communications solution to support consumers during the pandemic.

Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG

by Zacks Equity Research

Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG

Here's Why You Should Add LabCorp (LH) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about LabCorp (LH) on increasing demand for COVID-19 tests as well as robust first-quarter 2020 results.

Urmimala Biswas headshot

5 PEG-Based Value Stocks to Buy Amid the Coronavirus Crisis

by Urmimala Biswas

While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.

Trina Mukherjee headshot

Diagnostic Testing Remains Crucial in Combatting Coronavirus

by Trina Mukherjee

Let's keep a watch on three stocks that are focused on offering advanced diagnostic testing to fight against coronavirus.

LabCorp's New Website Offers Patients Coronavirus Trial Details

by Zacks Equity Research

LabCorp's (LH) Covance business benefits from collaborations with leading pharmaceutical and biotechnology companies.

Surging Earnings Estimates Signal Upside for LabCorp (LH) Stock

by Zacks Equity Research

LabCorp (LH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

LH vs. ALGN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LH vs. ALGN: Which Stock Is the Better Value Option?

LabCorp (LH) Up 6.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

LabCorp Partners With Medable to Expand Technology Ecosystem

by Zacks Equity Research

LabCorp (LH) expands technology ecosystem to accelerate the adoption of decentralized clinical trials by collaborating with Medable.

Urmimala Biswas headshot

LabCorp's (LH) Q1 Earnings Beat Estimates, Margins Down

by Urmimala Biswas

LabCorp's (LH) Covance Drug Development revenues improve despite COVID-19 hurdles.

LabCorp (LH) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

LabCorp (LH) delivered earnings and revenue surprises of 34.66% and 3.89%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Products Stock Earnings on Apr 29: BSX, ALGN & More

by Urmimala Biswas

Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products.